beta-amyloid plaques — Drug Target
All drugs that target beta-amyloid plaques — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- Amyvid, Intravenous Solution · Universidad Central del Caribe · PET imaging agent · Neurology
Amyvid is a positron emission tomography (PET) imaging agent that binds to beta-amyloid plaques in the brain.